Elipic Partners Strategy

Partnering with founders and investors to build category‑defining
companies in healthcare, nutrition, and sports

Strategy Overview

Two complementary products execute the same operator‑led thesis with distinct risk‑return profiles and liquidity pathways.

Product A: Corporate Holding Companies

Thesis

Controlling ownership across sectors engineered for accelerated scale, operator alignment, and long‑term value creation.

Financial attributes

Targeted dividend flows and return of capital, with upside from platform multiple expansion, inorganic growth, and capital structure optimization.

Product B: Secondaries Fund

Thesis

Acquire secondary stakes in high‑potential companies and portfolios with de‑risked trajectories and clearly defined exit pathways.

Financial attributes

Prioritizes liquidity events and accelerated distributions, with balanced exposure to manage risk and optimize capital rotation.

Our Operating Edge

Execution

Seasoned operators leading from strategy to scale. Embedding operating craftbooks across organization design, GTM, ops, and active board engagement.

Technology

AI is the operating layer. From diagnostics to demand forecasting and margin modeling, compounding speed, precision, and performance.

Governance

Global-standard governance built in from day one. Finance, legal, tax, compliance, and regulatory systems designed to protect capital and ensure institutional readiness.

Talent

Sector‑native talent across every layer from management to boardroom. High‑performance teams, operator‑aligned leadership, and value‑driven governance built in and incentivized for long‑term outcomes.

Interested in learning more?

Get in Touch